Parikh Anand Kiran
SEC CIK 2111813 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| FTH | Faeth Therapeutics, Inc. | Pres, CEO, Dir | 764.2K | $55.4K | — | 3 | 2026-06-15 | 2026-06-22 |
Most active insiders at FTH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MILLENNIUM MANAGEMENT LLC | 10% | $1.34M | $704.5K |
| 2 | STEPHENSON BRIAN C | CFO | $1.13M | — |
| 3 | Peyer James | 10%, See remarks below | — | $787.8K |
| 4 | Cambrian BioPharma Inc | 10% | — | $787.8K |
| 5 | Parikh Anand Kiran | Pres, CEO, Dir | $55.4K | — |
| 6 | Hahn Stephen M. | Dir | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-24 18:55 | 2026-06-22 | FTH | Faeth Therapeutics, Inc. | Parikh Anand Kiran | Pres, CEO, Dir | P - Purchase | $19.76 | +2,806 | 764.2K | +0.4% | +$55.4K |
| DM | 2026-06-24 18:55 | 2026-06-22 | FTH | Faeth Therapeutics, Inc. | Parikh Anand Kiran | Pres, CEO, Dir | M - OptEx | $1.16 | +53.5K | 817.7K | +7% | +$62.0K |
| D | 2026-06-16 16:38 | 2026-06-15 | FTH | Faeth Therapeutics, Inc. | Parikh Anand Kiran | Pres, CEO, Dir | C - Cnv Deriv | — | +761.4K | 761.4K | New | — |
Purchase Sale Sale after option exercise All abbreviations